Ji Eun Lee

Ji Eun Lee

Auto-generated profile, based on publicly available information

Ji Eun Lee

Blood Cancer Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2025 in Blood
Verified
Journal Article
Closed access
SKSojeong Kim
Sojeong Kim
JKJeong-Eun Kwak
Jeong-Eun Kwak
JKJune-Young Koh
June-Young Koh
JLJi Eun Lee
Ji Eun Lee
HKHye Won Kook
Hye Won Kook
Hyunsoo ChoHyunsoo Cho
Hyunsoo Cho
Emerging evidence indicates that CD4+ T cells contribute to antitumor immunity beyond their traditional roles as helpers or regulators. However, the specific subset of CD4+ T cells mediating beneficial outcomes in patients with multiple myeloma remains unclear. Here, we performed single-cell RNA sequencing and T-cell receptor sequencing on CD4+ T cells sorted from the bone marrow of patients across the stages of myeloma progression. We identified several distinct states of CD4+ cytotoxic T lymphocytes (CTLs) that were significantly increased and clonally expanded in patients with myeloma. CD4+ CTLs displayed transcriptional and phenotypic characteristics indicative of cytotoxicity, demonstrating their ability to directly kill myeloma cells. This cytotoxicity, however, was abrogated by NKG2D blockade. Notably, the abundance of NKG2D+CD4+ CTLs correlated with improved survival in patients with myeloma. Our findings suggest that harnessing CD4+ CTLs could lead to novel strategies for enhancing immunotherapy outcomes in multiple myeloma.

1 January 2025 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
JKJiyoung Agatha Kim
Jiyoung Agatha Kim
JLJi Eun Lee
Ji Eun Lee
KBKunhyung Bae
Kunhyung Bae
SASung Soo Ahn
Sung Soo Ahn
Kim JA, et al. Yonsei Med J. 2025 Mar;66(3):151-159. https://doi.org/10.3349/ymj.2024.0001